Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | RXRA | P19793 | 3/20 | 0.32 |
| ▸ | RXRB | P28702 | 2/20 | 0.32 |
| ▸ | RXRG | P48443 | 2/20 | 0.32 |
| ▸ | RARA | P10276 | 3/20 | 0.31 |
| ▸ | RARB | P10826 | 3/20 | 0.31 |
| ▸ | RARG | P13631 | 3/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.31 |
| ▸ | DRD3 | P35462 | 1/20 | 0.31 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 0.31 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12813496 | 0.66 | GAA (0.37) | GAATSHRCYP1A2RXRARXRB | |
| SCHEMBL12813429 | 0.66 | GAA (0.40) | GAATSHRCYP1A2RXRARXRB | |
| SCHEMBL12813385 | 0.66 | GAA (0.37) | GAATSHRCYP1A2RXRARXRB | |
| SCHEMBL9050071 | 0.65 | ALDH1A1 (0.35) | TSHRCYP1A2RXRARXRBRXRG | |
| SCHEMBL10948979 | 0.61 | CYP1A2 (0.36) | TSHRCYP1A2ALDH1A1LMNAPTGS1 | |
| SCHEMBL10744254 | 0.61 | GAA (0.35) | GAATSHRCYP1A2RXRARXRB | |
| SCHEMBL547818 | 0.60 | — | — | |
| SCHEMBL21755917 | 0.60 | CYP1A2 (0.34) | GAATSHRCYP1A2ALDH1A1LMNA | |
| SCHEMBL21755930 | 0.60 | ALDH1A1 (0.34) | GAATSHRCYP1A2RXRARXRB | |
| SCHEMBL5720417 | 0.57 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012134971-A2 | OPSIN-BINDING LIGANDS, COMPOSITIONS AND METHODS OF USE | BIKAM PHARMACEUTICALS, INC. (US) | 2012-10-04 | — | — | WO | disclosed |
| WO-2011155983-A1 | OPSIN-BINDING LIGANDS, COMPOSITIONS AND METHODS OF USE | BIKAM PHARMACEUTICALS INC. (US) | 2011-12-15 | — | — | WO | disclosed |